Bottom Line: The risk of detecting cervical precancer eight years after a negative human papillomavirus (HPV) screening was found to be similar to the risk after three years (the commonly recommended ...

The risk of developing cervical neoplasia 8 years after human papillomavirus (HPV) testing was similar to 3 years after a negative Pap test, a large longitudinal cohort study showed. Patients with one ...

Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test to triage human papillomavirus (HPV)-positive cervical cancer screening test results Dual-stain biomarkers aid in ...

Superb Dx and AIxMed team up to bring AI-driven urine cytology to Superb Dx’s reference lab capabilities, targeting ...

Please provide your email address to receive an email when new articles are posted on . HPV-based vs. cytology-based screening was tied to lower risks for invasive cervical cancer. Adverse events were ...

Cervical cancer has historically been a significant public health issue worldwide, causing substantial morbidity and mortality among women. Over recent decades, advances in screening, vaccination, and ...

Combining high-risk human papillomavirus (hrHPV)–based screening with cytologic triage detected two times more cases of grade 2+ cervical intraepithelial neoplasia (CIN2+) than cytology alone, ...

The addition of human papillomavirus (HPV) DNA testing to either conventional or liquid-based cytology has previously been shown to increase detection rates of high-grade cervical intraepithelial ...

According to the most recent statistics available, cancers of the urinary tract are an important public health issue, impacting some 386,000 people worldwide in 2008. 1 Urothelial bladder cancer is ...